好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Temporal Trends in Hypertensive Subarachnoid Hemorrhage Mortality in the United States, 1999-2023: A Population-based Joinpoint Regression Analysis
Cerebrovascular Disease and Interventional Neurology
P7 - Poster Session 7 (8:00 AM-9:00 AM)
4-013
To analyze temporal trends in SAH-related mortality among hypertensive patients in the U.S. from 1999–2023 using Joinpoint regression.
Subarachnoid hemorrhage (SAH) secondary to hypertension remains a major cerebrovascular cause of death. Despite advances in hypertension control and neurosurgical care, mortality patterns across demographic subgroups remain underexplored.
Mortality data were obtained from the CDC WONDER database using ICD-10 codes I60 (subarachnoid hemorrhage) and I10–I15 (hypertensive diseases). Age-adjusted mortality rates (AAMR) per 100,000 population were analyzed by sex, race, census region, and urbanization level, and crude rates (CR) by age group. Trends were assessed using Joinpoint regression to estimate the Annual Percent Change (APC) and Average Annual Percent Change (AAPC) with 95% confidence intervals (CIs).
From 1999–2023, 40,198 deaths were attributed to hypertensive SAH. Overall AAMR (0.725) increased significantly (AAPC = 0.97%, p = 0.031). Females had higher AAMR (0.80) than males (0.62), but mortality rose only among males (AAPC = 1.91%, p < 0.001). Asian/Pacific Islanders had the highest AAMR (1.27) yet showed a decline (AAPC = −1.33%, p < 0.001); rates were stable among Black individuals, while White populations showed an increase (AAPC = 1.37%, p < 0.001). Regional variation was evident (West 0.90, South 0.72, Midwest 0.65, Northeast 0.63), with rising mortality in the South (AAPC = 1.64%, p = 0.001) and West (AAPC = 1.07%, p = 0.018). Rural areas showed increasing mortality (AAPC = 2.02%, p = 0.012) despite slightly lower AAMR (0.66) than urban areas (0.71). The steepest increases occurred among ages 75–84 (AAPC = 6.52%, p = 0.004) and 85+ (AAPC = 5.43%, p < 0.001). Columbia showed persistently high but stable rates, whereas Nevada exhibited the sharpest recent rise.
Mortality from hypertensive SAH is rising, especially among males, elderly adults, Whites, and rural populations, highlighting disparities in hypertension control and cerebrovascular care.
Authors/Disclosures
Muhammad Moiz Javed, MD
PRESENTER
Dr. Javed has nothing to disclose.
Ammad Abid, MBBS Dr. ABID has nothing to disclose.
Arham K. Farooq, Sr., MBBS Dr. Farooq has nothing to disclose.
Annas Mehzam, MBBS Dr. Mehzam has nothing to disclose.
Muhammad Usman Iqbal, MBBS Mr. Iqbal has nothing to disclose.
Muhammad Nabeel Saddique, MBBS Mr. Saddique has nothing to disclose.
Asim Abdullah Mr. Abdullah has nothing to disclose.